ICDM 2023

CS1 Diabetes and metabolism journal session Best papers at DMJ 2022 Chair(s): Kyung Mook Choi, Won Young Lee
Friday 20 October, 14:00~15:00
Room 5 (2F)

Diabetes and Metabolism Journal (dmj) is the official journal of the Korean Diabetes Association (KDA) and the 2022 impact factor of dmj is 5.9. This session consists of a time to share the research contents of five excellent papers carefully selected through the fair review process of the publication committee among the original articles published in 2022. We cordially ask for your continued support for dmj's development in the future.

CS1-1 Eun Hee Kim University of Ulsan, Korea: Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus

CS1-2 Jae Hyun Bae Korea University, Korea: Efficacy and safety of self-titration algorithms of insulin glargine 300 units/ml in individuals with uncontrolled type 2 diabetes mellitus (the Korean titration study): a randomized controlled trial

CS1-3 Soyeon Kang The Catholic University of Korea, Korea: Reproductive life span and severe hypoglycemia risk in postmenopausal women with type 2 diabetes mellitus

CS1-4 Man-Rong Xu Shanghai Jiao Tong University, China: Serum retinol-binding protein levels are associated with nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a real-world study

CS1-5 Kyuho Kim The Catholic University of Korea, Korea: Glucose profiles assessed by intermittently scanned continuous glucose monitoring system during the perioperative period of metabolic surgery

CS2 K-ACCORD session Rethinking landmark trials in T2DM: beyond the legacy Chair(s): Sin Gon Kim, Ramzi A. Ajjan
Friday 20 October, 16:00~17:40
Room 5 (2F)

In the history of diabetes management, there have been multiple shifts in the paradigm of type 2 diabetes therapy. The UKPDS demonstrated that intensive glycemic control in early diabetic patients reduces the risk of complications. On the other hand, the ACCORD study revealed possible risks associated with intensive glycemic control in advanced diabetic patients. Recent Cardiovascular Outcome Trials (CVOT) results are challenging the paradigm of glycemic control. In this session, we aim to summarize the implications of the landmark trials of type 2 diabetes and propose the future direction of diabetes treatment with introducing the REMATCH trial.

CS2-1 Rodica Pop-Busui University of Michigan, USA: From ACCORD to GRADE: lessons and more steps forward

CS2-2 Ramzi A. Ajjan University of Leeds, UK: UKPDS vs recent CVOTs: does glycemic control still matter

CS2-3 Sin Gon Kim Korea University, Korea: REMATCH: beyond ACCORD and GRADE

Panel discussion

CS2-Panel 1
Jun Sung Moon Yeungnam University, Korea
CS2-Panel 2
Nam Hoon Kim Korea University, Korea
CS2-Panel 3
Yong-ho Lee Yonsei University, Korea

CS3 Committee of the health insurance and legislation session (K) Diabetes and digital therapeutics Chair(s): Chong Hwa Kim, Jaehyoung Cho
Friday 20 October, 16:00~17:40
Room 101 (1F)

This session will discuss the intersection of Diabetes and Digital Health. Reviewing current landscape, anticipate future trends, and uncover government policy directions. Discover how tech innovations are revolutionizing diabetic care, potentially leading to improved management and healthier outcomes.

CS3-1 Dughyun Choi Soonchunhyang University, Korea: Clinical usefulness of digital therapeutics on diabetes management

CS3-2 Junhwan Kim Kakao Healthcare, Korea: Digital health policy direction from the corporate side

Panel discussion

CS3-Panel 1
Sangjoon Park Soonchunhyang University, Korea
CS3-Panel 2
Jung Hwa Lee Kyung Hee University Hospital at Gangdong, Korea
CS3-Panel 3
Miyeong Kim Korean Society of Type 1 Diabetes, Korea

	사전등록 (~2023년 9월 15일까지)		현장등록 (2023년 10월 19일~21일)
	KDA회원	비회원	KDA회원	비회원
전문의(개원의, 교수, 봉직의, 전임의 포함)	₩280,000	₩350,000	₩370,000	₩450,000
전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사 및 기타 (군의관 및 공중보건의 포함)	₩180,000	₩230,000	₩250,000	₩270,000
저녁 식사	₩30,000

Program details

평점안내 (For Korean)